Formosa Laboratories, Inc.

Total Valuation

Formosa Laboratories, Inc. carries a market capitalization of 6.63B, placing it among publicly traded companies globally. Its enterprise value stands at 9.16B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Formosa Laboratories, Inc. currently has 120.26M shares outstanding.

Valuation Ratios

Formosa Laboratories, Inc. trades at a trailing price-to-earnings ratio of 16.18. The price-to-sales ratio is 1.47, and the price-to-book ratio stands at 1.94.

Enterprise Valuation

On an enterprise value basis, Formosa Laboratories, Inc. trades at an EV/EBITDA multiple of 11.54 and an EV/FCF ratio of 4.19. The EV/Sales ratio of 1.89 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 11.54 provides insight into valuation relative to core operating earnings.

Financial Position

Formosa Laboratories, Inc. maintains a current ratio of 1.91, meaning it holds 1.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 41.63, indicating elevated leverage, while an interest coverage ratio of 23.97 demonstrates strong ability to service its debt obligations.

Financial Efficiency

Formosa Laboratories, Inc. posts a return on equity of 12.40 and a return on invested capital of 5.03.

Taxes

Over the trailing twelve months, Formosa Laboratories, Inc. has paid 105.72M in income taxes, reflecting an effective tax rate of 21.07.

Stock Price Statistics

Formosa Laboratories, Inc.'s stock has declined approximately -17.88376% over the past 52 weeks. The 50-day moving average sits at 52.84, while the 200-day moving average is 57.80.

Income Statement

Over the trailing twelve months, Formosa Laboratories, Inc. generated 4.85B in revenue and converted that into 441.11M in net income, yielding earnings per share of 3.28. EBITDA reached 794.12M, while operating income came in at 794.12M.

Balance Sheet

Formosa Laboratories, Inc. holds 2.49B in cash and equivalents against 3.61B in total debt, resulting in a net debt position of 2.36B. Total book value stands at 3.68B, with working capital of 2.65B providing operational flexibility.

Cash Flow

Formosa Laboratories, Inc. produced 1.32B in operating cash flow over the past twelve months. After subtracting -843.12M in capital expenditures, free cash flow totaled 472.12M - equivalent to 3.92 per share.

Margins

Formosa Laboratories, Inc. operates with a gross margin of 41.89, reflecting its pricing power and cost economics. The operating margin of 16.37 and net profit margin of 9.09 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Formosa Laboratories, Inc.'s most recent stock split took place on August 20, 2013 with a 250:253 split ratio.

Scores

Formosa Laboratories, Inc. posts an Altman Z-Score of 1.88, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.